Functional Assays for Protein C Activity and Protein C Inhibitor Activity in Plasma

Margarethe Geiger; Teresa M White; John H Griffin

doi:10.1055/s-0038-1646532

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1989; 61(01): 086-092
DOI: 10.1055/s-0038-1646532

Original Article

Schattauer GmbH Stuttgart

Functional Assays for Protein C Activity and Protein C Inhibitor Activity in Plasma

Margarethe Geiger

The Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA, USA

,

Teresa M White

The Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA, USA

,

John H Griffin

The Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA, USA

› Author Affiliations

Abstract

PDF Download

Summary

An assay system for protein C (PC) activity and PC-inhibitor in plasma was developed. The assay was based on: (1) binding of PC to wells of a microtiter plate coated with a murine monoclonal anti-PC antibody (C3) that did not interfere with the activity or activation of PC; (2) activation of immobilized PC with Protac C; (3) incubation with or without a source of activated PC inhibitor; and (4) measurement of amidolytic activity using the substrate S-2366. The activity assay was specific for PC and sensitive to <1 μl of plasma or 4 ng PC. Inhibition of activated PC by plasma followed pseudo first order kinetics. Heparin caused a dose dependent increase in the inhibition rate with half maximal stimulation at approximately 3 U/ml and maximal stimulation at heparin concentrations ≥10 U/ml. This assay is suitable not only for determination of functional plasma levels of PC and PC inhibitor activities but also for kinetic studies of inhibition of activated PC in complex systems, such as plasma. Studies showed that urokinase interfered with the inhibition of APC by plasma inhibitor(s).

Key words

Protein C - Protein C inhibitor - Functional protein C assay - Functional protein C inhibitor assay

PDF (392 kb)

References

References
1 Esmon CT. (guest ed) Protein C. Sem Thromb Haemostas 1984; 10: 109-172
2 Witt I. (ed) Protein C - Biochemical and Medical Aspects. Walter de Gruyter & Co; Berlin: 1985. pp 1-195
3 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
4 Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human Factor VIII procoagulant protein by activated human protein C and its analogy with Factor V. Blood 1984; 63: 486-489
5 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
6 Hinsberg VW M van, Bertina RM, Wijngaarden Avan, Tilburg NH van, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985; 65: 444-451
7 Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985; 82: 1121-1125
8 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
9 Broekmans AW, Veltkamp JJ, Bertina R. Congenital protein C deficiency and venous thromboembolism. N Engl J Med 1983; 309: 340-344
10 Branson H, Katz J, Marble R, Griffin JH. Inherited protein C deficiency in a coumarin-responsive chronic relapsing purpura fulmi- nans syndrome in a neonate. Lancet 1983; 2: 1165-1168
11 Seligsohn U, Berger A, Abead M, Rubin L, Attias D, Zivelin A, Rappaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
12 Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980; 66: 1186-1189
13 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization J Biol Chem 1983; 258: 163-168
14 Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 1984; 95: 187-195
15 Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, Yamamoto S, Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily J Biol Chem 1987; 262: 611-616
16 Heeb MJ, Espana F, Geiger M, Collen D, Stump DC, Griffin JH. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 1987; 262: 15813-15816
17 Geiger M, Heeb MJ, Binder BR, Griffin JH. Competition of activated protein C and urokinase for a heparin dependent inhibitor. FASEB J 1988; 2: 2263-2267
18 Heeb MJ, Espana F, Geiger M, Collen D, Stump DC, Griffin JH. Immunological similarities between plasma and urinary protein C inhibitors (PCIs) and urinary urokinase inhibitor (UKI). Thromb Haemostas 1987; 58: 277 (Abstr 1017)
19 van der Meer FJ M, van Tilburg NH, van der Linden IK, Briet E, Bertina RM. A second inhibitor of activated protein C (APC). Thromb Haemostas 1987; 58: 277 (Abstr 1018)
20 Ikeda K, Stenflo J. A radioimmunoassay for protein C. Thromb Res 1985; 39: 297-306
21 Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu MJ. A new method for the estimation of protein C by ELISA. Thromb Res 1984; 36: 579-589
22 Sala N, Owen WG, Collen D. A functional assay of protein C in human plasma. Blood 1984; 63: 671-675
23 Comp PC, Nixon RR, Esmon CT. Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood 1984; 15-21
24 Bertina RM, Broekmans AW, Krommenhoek-van EsC, van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemostas 1984; 51: 1-5
25 Francis Jr RB. A simplified PTT-based protein C activity assay using the thrombin-thrombomodulin complex. Thromb Res 1986; 37: 337-344
26 Exner T, Koutts J. Simple immunochromometric assay for protein C activity. J Lab Clin Med 1986; 107: 405-411
27 Martinola JL, Stocker K. Fast functional protein C assay using Protac^®, a novel protein C activator. Thromb Res 1986; 43: 253-264
28 Canfield WK, Kisiel W. Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease. J Clin Invest 1982; 70: 1260-1272
29 Gardiner JE, Griffin JH. Studies on human protein C inhibitor in normal and Factor V/VIII deficient plasmas. Thromb Res 1984; 36: 197-203
30 Stocker K, Fischer H, Meier J, Brogli M, Svendsen L. Protein C activators in snake venoms. Behring Institute Mitteilungen (Behring Institute Research Communications) 1986; 79: 37-47
31 McConahey PJ, Dixon FJ. A method of trace iodination of proteins for immunological studies. Int Arch Allergy Immunol 1966; 29: 185-189
32 Jameson GW, Roberts DV, Adams RW, Kyle WS A, Elmore DT. Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectro- fluorimetric titration. Biochem J 1973; 131: 107-117
33 Heeb MJ, Schwarz HP, White TM, Laemmle B, Berrettini M, Griffin JH. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res 1988; 52: 33-43
34 Ey PL, Prowse SJ, Jenkin CR. Isolation of pure IgG, IgG_2a, IgG_2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 1978; 15: 429-436
35 Clezardin P, McGregor JL, Nanach M, Boukerche H, Dechavanne M. One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion exchange column. J Chromatography 1985; 319: 67-77
36 Geiger M, Griffin JH, Binder BR. Plasminogen activator inhibitor 3 (PAI-3, protein C inhibitor): Purification, characterization and specificity. Fibrinolysis 1988; 2 Suppl (Suppl. 01) 56 (Abstr 127)